ATE127020T1 - Pharmazeutische zusammensetzungen mit eierschalenbestandteilen und ihre herstellung und verwendung. - Google Patents

Pharmazeutische zusammensetzungen mit eierschalenbestandteilen und ihre herstellung und verwendung.

Info

Publication number
ATE127020T1
ATE127020T1 AT89111364T AT89111364T ATE127020T1 AT E127020 T1 ATE127020 T1 AT E127020T1 AT 89111364 T AT89111364 T AT 89111364T AT 89111364 T AT89111364 T AT 89111364T AT E127020 T1 ATE127020 T1 AT E127020T1
Authority
AT
Austria
Prior art keywords
preparation
pharmaceutical compositions
egg shell
compositions containing
containing egg
Prior art date
Application number
AT89111364T
Other languages
German (de)
English (en)
Inventor
Karol Dr Michalek
Original Assignee
Biomin Akciova Spolocnost
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=5387317&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE127020(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biomin Akciova Spolocnost filed Critical Biomin Akciova Spolocnost
Application granted granted Critical
Publication of ATE127020T1 publication Critical patent/ATE127020T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT89111364T 1988-06-24 1989-06-22 Pharmazeutische zusammensetzungen mit eierschalenbestandteilen und ihre herstellung und verwendung. ATE127020T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS884454A CS445488A1 (en) 1988-06-24 1988-06-24 Biological preparation for osteo- and chondropathies,physiopathological disorders and diseases arisen on base of mineral deficiency in human organism treatment

Publications (1)

Publication Number Publication Date
ATE127020T1 true ATE127020T1 (de) 1995-09-15

Family

ID=5387317

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89111364T ATE127020T1 (de) 1988-06-24 1989-06-22 Pharmazeutische zusammensetzungen mit eierschalenbestandteilen und ihre herstellung und verwendung.

Country Status (7)

Country Link
US (1) US5045323A (cs)
EP (1) EP0347899B1 (cs)
JP (1) JPH0256434A (cs)
AT (1) ATE127020T1 (cs)
CS (1) CS445488A1 (cs)
DE (1) DE68924006T2 (cs)
RU (1) RU1783984C (cs)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS445488A1 (en) * 1988-06-24 1991-01-15 Karol Mvdr Michalek Biological preparation for osteo- and chondropathies,physiopathological disorders and diseases arisen on base of mineral deficiency in human organism treatment
JPH0592122U (ja) * 1992-05-11 1993-12-14 株式会社クラウン・パッケージ 段ボ−ル製トレ−
DE4422613A1 (de) * 1994-06-28 1996-01-04 Aar Pharma Adler Apotheke Putamen ovi
DE19751681A1 (de) * 1997-11-21 1999-07-29 Michael O Ruepp Aar Pharma Verwendung von Putamen ovi
US6344217B1 (en) 1994-06-28 2002-02-05 Aar Pharma Adler Apotheke Putamen OVI
NL9401958A (nl) * 1994-11-23 1996-07-01 Friesland Brands Bv Met eierschalenmeel verrijkt melkprodukt.
NL1002400C2 (nl) * 1996-02-20 1997-08-21 Friesland Brands Bv Oraal calcitonine-preparaat en werkwijze voor het winnen van calcitonine.
FR2746652B1 (fr) * 1996-03-28 1998-05-15 Dupoirieux Laurent Pierre Utilisation de la coquille d'oeuf comme implant osseux et son mode de fabrication
NO303819B1 (no) * 1996-11-20 1998-09-07 Drymed As Anvendelse av t°rkede, fertiliserte h°nse-egg for fremstilling av anti-depressive midler
US7007806B2 (en) * 1997-03-18 2006-03-07 The Penn State Research Foundation Method and apparatus for separating a protein membrane and shell material in waste egg shells
CN1250396A (zh) 1997-03-18 2000-04-12 宾州研究基金会 废蛋壳组份的回收
US5716649A (en) * 1997-03-20 1998-02-10 Nam; Wal Hee Process of increasing calcium content in an aqueous solution
US8859010B2 (en) * 2003-05-29 2014-10-14 Biosynergy, Inc. Method of producing eggshell powder
RU2264221C1 (ru) * 2004-02-24 2005-11-20 Федеральное государственное образовательное учреждение высшего профессионального образования Ставропольский государственный аграрный университет Способ приготовления комплексного иммунного модулятора
NL1031399C2 (nl) * 2006-03-17 2007-09-18 Biohorma B V Samenstelling voor het voorkomen, verminderen of behandelen van verlies van botdichtheid.
US20100041606A1 (en) * 2008-07-10 2010-02-18 Ilan Elias Methods of Use of Eggshell Polypeptides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558771A (en) * 1968-02-12 1971-01-26 Leslie L Balassa Process for using eggshell compositions for promoting wound healing
CS445488A1 (en) * 1988-06-24 1991-01-15 Karol Mvdr Michalek Biological preparation for osteo- and chondropathies,physiopathological disorders and diseases arisen on base of mineral deficiency in human organism treatment

Also Published As

Publication number Publication date
DE68924006T2 (de) 1996-01-25
US5045323A (en) 1991-09-03
RU1783984C (ru) 1992-12-23
DE68924006D1 (de) 1995-10-05
CS445488A1 (en) 1991-01-15
EP0347899A3 (en) 1990-03-28
EP0347899B1 (en) 1995-08-30
EP0347899A2 (en) 1989-12-27
JPH0256434A (ja) 1990-02-26

Similar Documents

Publication Publication Date Title
ATE127020T1 (de) Pharmazeutische zusammensetzungen mit eierschalenbestandteilen und ihre herstellung und verwendung.
BR9813373A (pt) Composto, processo para a preparação do mesmo, composição farmacêutica, processo para a preparação da mesma, uso de um composto, e, processos para efetuar imunossupressão e para tratar ou reduzir o risco de uma doença das vias aérias obstrutiva reversìvel em um paciente
UA42747C2 (uk) Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту
ATE256475T1 (de) Verwendung von follistatin zur herstellung eines arzneimittels zur behandlung von muskuläre krankheiten
NO890259D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
IL75536A (en) Crystalline calcium pseudomonate,its preparation and pharmaceutical and veterinary compositions comprising it
DE69521536D1 (de) Zusammensetzungen die G-CSF und ein TNF-Bindungsprotein enthalten
GR3025488T3 (en) Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions
EP0376251A3 (en) An anticoagulant substance obtained from urine
ATE82127T1 (de) N-acetylglucosamin-zubereitungen zur buccalen anwendung.
DE69420776D1 (de) Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer
BG105275A (en) Tan-1057 derivatives
ATE192923T1 (de) Verwendung von boswelliasäure zur behandlung von hirntumoren
ATE5256T1 (de) Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
DE3771584D1 (de) Zusammensetzungen und anwendung von interleukin-2 und/oder interferon-beta und des tumor-necrosis-faktors fuer eine kombinationstherapie oder zur herstellung von arzneimitteln oder formulierungen.
DK0821969T3 (da) Medicinsk sammensætning omfattende TCF-II
IL91152A0 (en) Furylthiazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
DE69113773D1 (de) Verwendung von 3-aryl-5-alkylthio-4H-1,2,4-triazolen zur Behandlung von Überreflexen infolge von Rückenmarkstrauma.
HU9403783D0 (en) Use of bradykinin-antagonists for producing pharmaceutical compositions for treating virus diseases
KR0177821B1 (en) Pharmaceutical compositions containing 1,2-benzopyrone derivatives for the treatment of malignant tumours in humans
ATE175349T1 (de) Verwendung von etofibrat und pharmazeutische zusammensetzungen, enthaltend etofibrat, zur behandlung der diabetischen angio- und retinopathie
HUT60145A (en) Process for producing pharmaceutical composition comprising human interleukin-2 and suitable for treating pneumothorax
ATE96150T1 (de) Thioester und dessen verwendung zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von ischaemie und von reperfusionsyndromen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee